A MoS based silver-doped ZnO nanocomposite and its antibacterial activity against β-lactamase expressing .

Multidrug-resistant (MDR) Gram-negative bacteria including are increasingly resistant to current antibiotics. Among the strategies implemented to eradicate such MDR pathogens, approaches based on two-dimensional (2D) nanomaterials have received considerable attention. In particular, the excellent physicochemical properties of 2D molybdenum disulfide (MoS) nanosheets, including a high surface area, good conductivity, and good surface retention, are advantageous for their use as bactericidal agents.